Biocon gets recognised as ASIA IP ELITE for 4th consecutive year

Biocon Biologics Debuts on the ASIA IP ELITE 2019 List

Biocon has been recognised as the ASIA IP ELITE for the fourth year in a row and its wholly-owned subsidiary Biocon Biologics makes its debut on this prestigious list in 2019 by the IP Business Congress Asia {IPBC Asia) for robust Intellectual Property (IP) management and consistent IP value creation.

Powered by Capital Market - Live News